MARKET

PALI

PALI

Palisade Bio Inc
NASDAQ
2.150
-0.050
-2.27%
After Hours: 2.140 -0.01 -0.47% 19:14 12/26 EST
OPEN
2.180
PREV CLOSE
2.200
HIGH
2.180
LOW
2.102
VOLUME
1.34M
TURNOVER
--
52 WEEK HIGH
2.590
52 WEEK LOW
0.5300
MARKET CAP
320.36M
P/E (TTM)
-0.7223
1D
5D
1M
3M
1Y
5Y
1D
Palisade Bio: Gut Prodrug For IBD With Catalysts
Seeking Alpha · 4d ago
Weekly Report: what happened at PALI last week (1215-1219)?
Weekly Report · 5d ago
Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know
NASDAQ · 12/19 17:00
Weekly Report: what happened at PALI last week (1208-1212)?
Weekly Report · 12/15 09:11
Weekly Report: what happened at PALI last week (1201-1205)?
Weekly Report · 12/08 09:11
Palisade Bio Approves Key Proposals at Stockholder Meeting
TipRanks · 12/04 21:59
Palisade Bio appoints James Izanec as VP, clinical development
TipRanks · 12/02 13:55
*Palisade Bio Appoints James Izanec Vice Pres, Clinical Development >PALI
Dow Jones · 12/02 13:46
More
About PALI
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and advancing therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company’s lead product candidate, PALI-2108, is being developed as a treatment for patients living with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Fibrostenotic Crohn’s disease (FSCD). The Company is conducting a Phase I human clinical trial of its lead product candidate, PALI-2108, for the treatment of UC. In UC mouse models, the Company has demonstrated the dose-dependent efficacy of PALI-2108. It utilizes dextran sodium sulfate (DSS)-induced UC mouse models and targets engagement in oxazolone-induced colitis. PALI-2108 targets the key phosphodiesterase-4 (PDE4) in colon tissues and prevents it from breaking down cyclic Adenosine Monophosphate (cAMP) molecules which regulate inflammation in the body.

Webull offers Palisade Bio Inc stock information, including NASDAQ: PALI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PALI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PALI stock methods without spending real money on the virtual paper trading platform.